trending Market Intelligence /marketintelligence/en/news-insights/trending/OxOI9dINctMAJRSGHqGc6A2 content esgSubNav
In This List

BriaCell to undertake larger share consolidation to help list on exchange

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


BriaCell to undertake larger share consolidation to help list on exchange

BriaCell Therapeutics Corp. said it will consolidate a larger number of shares than previously communicated.

The Canadian biotechnology will undertake a reverse stock split of its shares at a ratio of 1-for-300 as opposed to 1-for-100 previously.

The move will help the immuno-oncology company apply for a listing on a recognized U.S. stock exchange. BriaCell's shares are listed on Canada's TSX Venture Exchange and the OTCQB in the U.S.